Screener
BPAY vs IBB
iShares FinTech Active ETF vs iShares Biotechnology ETF
Key differences
- IBB costs 0.11% less per year.
- IBB is significantly larger than BPAY — larger funds tend to be more liquid and less likely to close.
- BPAY is classified as alternative, while IBB is equity — different risk/return profiles.
- BPAY covers global markets; IBB covers north america.
- BPAY follows a active selection strategy; IBB uses index tracking.
- IBB has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BPAY | IBB | |
|---|---|---|
| Annual cost (TER) | 0.55% | 0.44% |
| Fund size (AUM) | $9M | $7.9B |
| Since | 2022 | 2001 |
| Dividend yield | 2.89% | 0.23% |
| Asset class | alternative | equity |
| Region | global | north america |
| Strategy | active selection | index tracking |
| CAGR 1Y | -5.8% | +39.0% |
| CAGR 3Y | +9.7% | +9.6% |
| CAGR 5Y | N/A | +2.7% |
| Sharpe 3Y | 0.36 | 0.38 |
| Volatility 1Y | 25.59% | 19.75% |
| Max drawdown | -33.62% | -39.82% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BPAY and IBB
Explore further